Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Changes in Gene Expression Following Ultherapy® Treatment

NCT02441036 is registered in ClinicalTrials.gov with Ulthera, Inc as lead sponsor.

NCT NCT02441036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02441036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Changes in Gene Expression Following Ultherapy® Treatment
Lead sponsor
Ulthera, Inc
Phase
Not applicable
Overall status
Terminated
Start date
May 1, 2015
Completion date
August 18, 2016
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

skin laxity